allowing pharmacists to authorize the use of certain drugs previously reserved for a physician's Rx

May 2012

FDA wants your input on allowing pharmacists to authorize the use of certain drugs previously reserved for a physician's Rx.

The idea is to improve access and lower health care costs.

In the past, FDA looked into whether we should have a "behind-the-counter" class of drugs that's between Rx and OTC.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Interactions "alert fatigue" caused by the increasing number of drug interaction warnings
Statins Statin patients will get fewer liver function tests
Supplements raspberry ketone for weight loss
Insomnia Intermezzo (in-ter-MET-zoe), a new low-dose zolpidem for middle-of-the-night awakening
Women's Health Natazia for heavy menstrual bleeding
Women's Health a more tailored approach to using hormone therapy for menopausal symptoms
Antithrombotics Brilinta (ticagrelor) for acute coronary syndrome
Ophthalmology taking an alpha-blocker can cause serious complications years later during cataract surgery
Antithrombotics Vitamin K will be used less often to reverse warfarin's anticoagulant effects
Alzheimer's Disease cholinesterase inhibitors (donepezil, etc) or memantine (Namenda) are beneficial for Alzheimer's
Practice allowing pharmacists to authorize the use of certain drugs previously reserved for a physician's Rx